Literature DB >> 22180648

Overexpression of angiopoietin-2 impairs myocardial angiogenesis and exacerbates cardiac fibrosis in the diabetic db/db mouse model.

Jian-Xiong Chen1, Heng Zeng, Jeff Reese, Judy L Aschner, Barbara Meyrick.   

Abstract

The angiopoietins/Tie-2 system is essential for the maintenance of vascular integrity and angiogenesis. The functional role of angiopoietin-2 (Ang-2) in the regulation of angiogenesis is dependent on other growth factors such as VEGF and a given physiopathological conditions. This study investigates the potential role of Ang-2 in myocardial angiogenesis and fibrosis formation in the diabetic db/db mouse. Diabetic db/db mice received intramyocardial administration of either adenovirus Ang-2 (Ad-CMV-Ang-2) or Ad-β-gal. The levels of Tie-2, VEGF, caspase-3, Wnt7b, fibroblast-specific protein-1 (FSP-1), and adhesion molecules (ICAM-1 and VCAM-1) expression were measured. Apoptosis, capillary density, and cardiac fibrosis were also analyzed in the db/db mouse hearts. Overexpression of Ang-2 suppressed Tie-2 and VEGF expression in db/db mouse hearts together with significant upregulation of Wnt7b expression. Overexpression of Ang-2 also sensitizes ICAM-1 and VCAM-1 expression in db/db mouse hearts. Immunohistochemical analysis revealed that overexpression of Ang-2 resulted in a gradual apoptosis as well as interstitial fibrosis formation, these leading to a significant loss of capillary density. Data from these studies were confirmed in cultured mouse heart microvascular endothelial cells (MHMEC) exposed to excessive Ang-2. Exposure of MHMEC to Ang-2 resulted in increased caspase-3 activity and endothelial apoptosis. Knockdown of Ang-2 attenuated high glucose-induced endothelial cell apoptosis. Further, counterbalance of Ang-2 by overexpression of Ang-1 reversed loss of capillary density and fibrosis formation in db/db mouse hearts. Our data demonstrate that Ang-2 increases endothelial apoptosis, sensitizes myocardial microvascular inflammation, and promotes cardiac fibrosis and thus contributes to loss of capillary density in diabetic diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180648      PMCID: PMC3322731          DOI: 10.1152/ajpheart.00866.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  37 in total

1.  Effects of hypoxia/reoxygenation on angiogenic factors and their tyrosine kinase receptors in the rat myocardium.

Authors:  P S Ray; H Sasaki; T Estrada-Hernandez; L Zu; N Maulik
Journal:  Antioxid Redox Signal       Date:  2001-02       Impact factor: 8.401

2.  Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion.

Authors:  T N Lin; C K Wang; W M Cheung; C Y Hsu
Journal:  J Cereb Blood Flow Metab       Date:  2000-02       Impact factor: 6.200

3.  FrzA, a secreted frizzled related protein, induced angiogenic response.

Authors:  Pascale Dufourcq; Thierry Couffinhal; Jérome Ezan; Laurent Barandon; Catherine Moreau; Danièle Daret; Cécile Duplàa
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

Review 4.  The wnt-frizzled cascade in cardiovascular disease.

Authors:  Marielle E van Gijn; Mat J A P Daemen; Jos F M Smits; W Matthijs Blankesteijn
Journal:  Cardiovasc Res       Date:  2002-07       Impact factor: 10.787

5.  Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF).

Authors:  Richard P Visconti; Charlene D Richardson; Thomas N Sato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-04       Impact factor: 11.205

6.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Authors:  Ivan B Lobov; Peter C Brooks; Richard A Lang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-05       Impact factor: 11.205

7.  Increased expression of angiopoietin-2 and Tie2 receptor in a rat model of myocardial ischaemia/reperfusion.

Authors:  Kou-Gi Shyu; Chih-Chuan Chang; Bao-Wei Wang; Peiliang Kuan; Hang Chang
Journal:  Clin Sci (Lond)       Date:  2003-09       Impact factor: 6.124

8.  Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay.

Authors:  N A Y Chung; A J Makin; G Y H Lip
Journal:  Eur J Clin Invest       Date:  2003-07       Impact factor: 4.686

9.  Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.

Authors:  Laurent Barandon; Thierry Couffinhal; Jérome Ezan; Pascale Dufourcq; Pierre Costet; Philippe Alzieu; Lionel Leroux; Catherine Moreau; Danièle Dare; Cécile Duplàa
Journal:  Circulation       Date:  2003-10-27       Impact factor: 29.690

10.  Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study.

Authors:  Sazan Rasul; Marie Helene Reiter; Aysegul Ilhan; Katharina Lampichler; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Cardiovasc Diabetol       Date:  2011-06-23       Impact factor: 9.951

View more
  31 in total

1.  Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.

Authors:  Minglin Pan; Ying Han; Aninda Basu; Anzhi Dai; Rui Si; Conor Willson; Angela Balistrieri; Brian T Scott; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2018-03-07       Impact factor: 4.249

Review 2.  Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus.

Authors:  Sazan Rasul; Ludwig Wagner; Alexandra Kautzky-Willer
Journal:  Endocrine       Date:  2012-07-21       Impact factor: 3.633

3.  Mechanism for reduced pericardial adhesion formation in hypercholesterolemic swine supplemented with alcohol.

Authors:  Antonio D Lassaletta; Louis M Chu; Nassrene Y Elmadhun; Michael P Robich; Zachary G Hoffman; David J Kim; Frank W Sellke
Journal:  Eur J Cardiothorac Surg       Date:  2012-09-18       Impact factor: 4.191

Review 4.  Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.

Authors:  Esam S B Salem; Guo-Chang Fan
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Contribution of Dual Oxidase 2 (DUOX2) to Hyper-Radiosensitivity in Human Gastric Cancer Cells.

Authors:  Duc M Nguyen; Palak R Parekh; Elizabeth T Chang; Navesh K Sharma; France Carrier
Journal:  Radiat Res       Date:  2015-07-24       Impact factor: 2.841

Review 6.  Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes.

Authors:  A M Isidori; M A Venneri; D Fiore
Journal:  J Endocrinol Invest       Date:  2016-06-25       Impact factor: 4.256

7.  Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Authors:  Heng Zeng; Xiaochen He; Xuwei Hou; Lanfang Li; Jian-Xiong Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-20       Impact factor: 4.733

8.  Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.

Authors:  Linda Alex; Ilaria Russo; Volodymir Holoborodko; Nikolaos G Frangogiannis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-07-13       Impact factor: 4.733

9.  Thrombospondin-1 induction in the diabetic myocardium stabilizes the cardiac matrix in addition to promoting vascular rarefaction through angiopoietin-2 upregulation.

Authors:  Carlos Gonzalez-Quesada; Michele Cavalera; Anna Biernacka; Ping Kong; Dong-Wook Lee; Amit Saxena; Olga Frunza; Marcin Dobaczewski; Arti Shinde; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2013-09-30       Impact factor: 17.367

10.  Impact of Syndecan-2-Selected Mesenchymal Stromal Cells on the Early Onset of Diabetic Cardiomyopathy in Diabetic db/db Mice.

Authors:  Kathleen Pappritz; Fengquan Dong; Kapka Miteva; Arpad Kovacs; Muhammad El-Shafeey; Bahtiyar Kerim; Lisa O'Flynn; Stephen Joseph Elliman; Timothy O'Brien; Nazha Hamdani; Carsten Tschöpe; Sophie Van Linthout
Journal:  Front Cardiovasc Med       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.